The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

Hungary's Premier Med and Semmelweis University have developed a minimally-invasive method for treating thyroid cancer.

Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb.

Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.